key: cord-0726982-0wtfefm5 authors: Przyklenk, B.; Bauernfeind, A.; Bertele, R. M.; Deinhardt, F.; Harms, K. title: Viral infections of the respiratory tract in patients with cystic fibrosis date: 1988-06-30 journal: Serodiagnosis and Immunotherapy in Infectious Disease DOI: 10.1016/0888-0786(88)90057-1 sha: efa93678d0afbf8ede21d3be518812bb09444f2a doc_id: 726982 cord_uid: 0wtfefm5 Abstract The role of viruses and bacteria in the development of respiratory tract infections causing acute deteriorations in lung function in patients with cystic fibrosis (CF) was investigated. Over a period of 30 months, 29 viral respiratory diseases were proven serologically by testing 275 sporadically collected sera from 75 patients with cystic fibrosis. The influenza A virus was the most frequent responsible viral pathogen (11 × ), followed by adenovirus (8 × ), influenza B virus (5 × ), parainfluenza virus type 3 (3 × ), parainfluenza virus type 1 and respiratory syncytial virus (RSV) (each of 1 × ). There was no serological evidence for infections with parainfluenza virus type 2, Mycoplasma pneumoniae or Coxiella burnetii. Deterioration of the clinical condition was found in 78% of the viral infections leading in 70% to hospital admission. Patients with cystic fibrosis and viral respiratory illnesses showed significantly more admissions to the hospital (3·2 ± 2·7) with a longer stay (90·6 ± 99·6 days). Nearly all viral episodes (93%) were accompanied or followed by a significant change of the microbial flora in the sputum especially by colonisation with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae. Seventy-two per cent of the viral infections occurred at home and 28% seemed to be hospital acquired. Our study emphasises the importance of improving antibacterial therapy at home to reduce the number of hospital admissions. Efforts for prophylaxis by vaccination or the use of chemotherapeutic agents should be made for the patients with cystic fibrosis. Respiratory viral infections are frequently responsible for the acute deterioration in the clinical condition of patients with underlying pulmonary disease eg chronic obstructive pulmonary disease or asthma'. They may also predispose to bacterial infections with Haemophilus injuenzae, Streptococcus pneumoniae or Staphylococcus awe&. Viral infections of the upper airways are not more frequent in patients with cystic fibrosis than in healthy controls, but the consequences tend to be more serious3. The major cause of acute deterioration of lung function in patients with cystic fibrosis is considered to be f To whom correspondence should be addressed. bacterial, especially P. aeruginosu, and in one-third this is preceded by a viral infection4 '. No previous study has compared quantitative bacteriological analyses of the sputum of patients with cystic fibrosis with a study of the immune responses against different viral agents in these patients. We therefore decided to determine to what extent respiratory tract infections with different viruses, Mycoplasma pneumoniae and Coxiella hurnetii contribute to the development of the acute bronchopulmonary exacerbations of cystic fibrosis. Seventy-five patients with laboratory and clinical signs of cystic fibrosis (38 female, 37 male; mean age 15.6 f 5.6, range 428 years) were included in this study. The Shwachman scores' for these patients lay between 35 and 95. During the study period (from November 1984 until April 1987), 275 sera were collected-between one and 18 serum samples from each patient, with a median value of 2. Fifty-two per cent of the serum samples were taken as outpatients at the Dr. von Hauner'sches Kinderspital Miinchen, 22% on admission to hospital and 26% during the hospital stay. The majority of the CF-patients (62/75) had a chronic infection (>6 months) with Pseudomonas aeruginosu at the beginning of the study. Five patients harboured P. aeruginosa only intermittently in their airways, whilst six patients were free of the pathogen throughout the study. Two patients with cystic fibrosis developed infection due to P. aeruginosu at the start of the study. Antibodies against influenza A, influenza B, influenza C viruses, parainfluenzae viruses (types 1,2 and 3), respiratory syncytial virus (RSV), adenovirus, M. pneumoniue and C. burnetii were determined by complement fixations. According to Enders9, titers > 1:64 for adenovirus and mycoplasma, > 1:32 for RSV, influenza A and B viruses and C. burnetii, and > 1: 16 for influenza C and parainfluenza viruses, or at least four-fold rises in paired serum samples, are considered to indicate a recent infection. Microbiological analyses of sputum'O were performed at the same time as the serology. Sputum sIgA-antibodies against the different lipopolysaccharide antigens of P. aeruginosa were evaluated as described elsewhere". For statistical calculations the Wilcoxon-Mann-White test, the x2 test and Fisher's exact test were used. With the criteria of Enders', previously described, we found 29 viral respiratory infectious episodes in the patients with cystic fibrosis taken into the study. Infections with two different viral agents at the same time occurred twice: influenza A and adenovirus; influenza B and adenovirus. Multiple respiratory tract viral infections were found in seven patients with at least 5 months between the two episodes ( Table 1 ). An at least four-fold titer rise in the complement-fixation test was seen in 25 of the 29 viral infections, and in four cases the first serum samples showed significantly elevated antibody titers (Table 2 ). Influenza A virus was the most frequent serologically proven viral pathogen (11 x ), followed by adenovirus (8 x ), influenza B virus (5 x ), parainfluenza virus serotype 3 (3 x ), parainfluenza virus serotype 1 and RSV (each of 1 x ). We found no serological evidence for infections with influenza ,C virus, parainfluenza virus of the serotype 2, M. pneumoniae or C. burnetii. There was no significant difference between the age distribution of the cystic fibrosis group with and without viral infection of the upper airways (mean age 14.4* 5.4 compared with 16.0 f 5.6). Infections with parainfluenzae viruses seem to appear more frequently in younger children, whereas the prevalence of the other viral agents in the different age groups was similar to the age distribution of all cystic fibrosis patients (Table 3 ). There was no correlation between carriage of P. aeruginosa and viral infection. Viral infections in cystic fibrosis occur during the entire year (Table 4 ). Infections with influenza A and B viruses are most frequent in winter and spring in contrast to parainfluenzae viruses and adenovirus which peak during the summer period. Patients with cystic fibrosis and viral infections of the upper airways required more frequent hospital admission (P